Archway acquires CSI to build out PDMA marketing fulfillment services
Parent will adapt its national network of 21 facilities to providing sample distribution and marketing services for pharma
Archway (Rogers, MN), a major player in fulfillment services in consumer goods, food and beverage and prepaid-card industries, has acquired Corporate Services Inc., which has served life sciences companies primarily. With the combination, Archway adds CSI’s one facility, in South Bend, IN, to its network of 21 facilities in 13 metropolitan areas nationwide.
The most direct activity the Archway/CSI combination will address is sample distribution and accountability, meeting the requirements of the Prescription Drug Marketing Act (PDMA) for pharma companies. The company has 4 million sq. ft. of distribution storage capacity, of which 700,000 is secured and temperature-controlled. Rich Rizzardi, SVP at Archway, says that the company’s overall vision is marketing operations management—the combined services to meet the fulfillment requirements of marketing departments in samples, literature and related promotional materials. “We’ll be looking to leverage our technology, providing a better total cost of ownership” of such services, he says. Of particular interest is Archway’s existing business in managing gift cards—a growing part of consumer marketing, and, now with co-pay and other types of patient incentives, a growing part of pharma marketing as well.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
